Myriad Genetics
MYGN
MYGN
186 hedge funds and large institutions have $1.33B invested in Myriad Genetics in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 69 increasing their positions, 72 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 17
1% less funds holding
Funds holding: 188 → 186 (-2)
29% less capital invested
Capital invested by funds: $1.88B → $1.33B (-$553M)
Holders
186
Holding in Top 10
1
Calls
$6.9M
Puts
$261K
Top Buyers
| 1 | +$41.3M | |
| 2 | +$10.2M | |
| 3 | +$4.03M | |
| 4 |
EARNEST Partners
Atlanta,
Georgia
|
+$3.52M |
| 5 |
D.E. Shaw & Co
New York
|
+$2.42M |
Top Sellers
| 1 | -$18.5M | |
| 2 | -$7.66M | |
| 3 | -$5.51M | |
| 4 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$3.85M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$3.11M |